Загрузка...
Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications
Advances in our understanding of the mechanisms driving castration-resistant prostate cancer have promoted the development of several new drugs including androgen receptor-directed therapy and chemotherapy. Concomitant docetaxel treatment at the beginning of hormonal therapy for metastatic prostate...
Сохранить в:
| Опубликовано в: : | Ther Adv Med Oncol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5524249/ https://ncbi.nlm.nih.gov/pubmed/28794807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017719215 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|